Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,810 | 7 | 45.4% |
| Travel and Lodging | $9,093 | 7 | 38.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,290 | 1 | 13.8% |
| Food and Beverage | $604.42 | 7 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $19,654 | 11 | $0 (2024) |
| Global Blood Therapeutics, Inc. | $2,350 | 3 | $0 (2021) |
| CSL Behring | $1,655 | 6 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $138.45 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,254 | 15 | PFIZER INC. ($16,599) |
| 2023 | $3,055 | 2 | PFIZER INC. ($3,055) |
| 2021 | $940.00 | 1 | Global Blood Therapeutics, Inc. ($940.00) |
| 2020 | $1,410 | 2 | Global Blood Therapeutics, Inc. ($1,410) |
| 2019 | $138.45 | 2 | PORTOLA PHARMACEUTICALS, INC. ($138.45) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $295.26 | General |
| 12/06/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $85.00 | General |
| 12/06/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 12/05/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $870.90 | General |
| 12/05/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $218.85 | General |
| 12/05/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/12/2024 | PFIZER INC. | VYNDAMAX (Drug) | Consulting Fee | Cash or cash equivalent | $4,935.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | PFIZER INC. | — | Travel and Lodging | Cash or cash equivalent | $165.41 | General |
| 10/12/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $113.47 | General |
| 07/31/2024 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,290.00 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $6,303.60 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $873.56 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $365.27 | General |
| Category: HEMATOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $82.50 | General |
| Category: HEMATOLOGY | ||||||
| 03/26/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $470.00 | General |
| 11/30/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,175.00 | General |
| 11/02/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| 04/07/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 12/16/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $235.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/17/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $1,175.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 04/11/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/20/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
About Dr. Melanie Fields, MD
Dr. Melanie Fields, MD is a Pediatrics healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255595658.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melanie Fields, MD has received a total of $23,797 in payments from pharmaceutical and medical device companies, with $18,254 received in 2024. These payments were reported across 22 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($10,810).
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Hematology-Oncology
- Location Saint Louis, MO
- Active Since 07/15/2008
- Last Updated 04/17/2025
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1255595658
Products in Payments
- OXBRYTA (Drug) $13,265
- VYNDAMAX (Drug) $4,935
- ANDEXXA (Biological) $138.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Saint Louis
Dr. Philip Spinella, Md, MD
Pediatrics — Payments: $286,187
Dr. David Balzer, Md, MD
Pediatrics — Payments: $209,718
Dr. Amy Clark, Do, DO
Pediatrics — Payments: $129,192
Dr. Jennifer Silva, Md, MD
Pediatrics — Payments: $128,336
Dr. Nico Dosenbach, Md, MD
Pediatrics — Payments: $115,400
Dr. Kel Vin Woo, M.d., Ph.d, M.D., PH.D
Pediatrics — Payments: $100,017